Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 803-805, 2003; 10.1373/49.5.803
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verhoeven, N. M.
Right arrow Articles by Jakobs, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verhoeven, N. M.
Right arrow Articles by Jakobs, C.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2003;49:803-805.)
© 2003 American Association for Clinical Chemistry, Inc.

Technical Briefs

Diagnostic Enzyme Assay That Uses Stable-Isotope-labeled Substrates to Detect L-Arginine:Glycine Amidinotransferase Deficiency

Nanda M. Verhoeven1,a, Danielle S.M. Schor1, Birthe Roos1, Roberta Battini2, Sylvia Stöckler-Ipsiroglu3, Gajja S. Salomons1 and Cornelis Jakobs1

1 Metabolic Unit, Department of Clinical Chemistry, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands

2 DUNPI Universita di Pisa-IRCCS Fondazione Stella Maris, 56018 Pisa, Italy

3 Department of Pediatrics, University Hospital and General Hospital of Vienna, A1090 Vienna, Austria

aauthor for correspondence: fax 31-20-4440305, e-mail N.Verhoeven@vumc.nl

The first 20% of the full text of this article appears below.

Arginine:glycine amidinotransferase (AGAT) is the enzyme responsible for the conversion of arginine and glycine into guanidinoacetate (GuAc) and ornithine in creatine biosynthesis. AGAT deficiency was recently described in two patients by Item et al. (1). These two patients [for whom the clinical details were first described by Bianchi et al. (2)] are mentally retarded and have severe creatine deficiency in the brain and decreased urinary GuAc.

Several methods for measuring AGAT activity have been published, but these methods are nonspecific because the measured ornithine formed during the assay can be of different origin (3)(4) or they are impracticable because they use radioactivity (1). We developed a new method in lymphocytes and lymphoblasts that uses stable-isotope-labeled substrates. We used L-[guanido-15N2]arginine and [U-13C,15N]glycine as substrates and analyzed the enzyme product [1,2-13C2,15N3]GuAc (after derivatization) by gas chromatography–mass spectrometry using [1,2-13C2]GuAc as internal standard. We applied this method to measure enzyme activities in lymphocytes and lymphoblasts of controls and in lymphoblasts from a patient affected with AGAT deficiency.

For lymphocyte isolation, whole venous blood from 16 control individuals was drawn into acid-citrate dextrose and stored at room temperature up to 48 h. Written consent was obtained from each participant.

Lymphoblast lines derived from six control individuals were maintained in RPMI-1640 supplemented with 100 mL/L fetal bovine serum and 10 mL/L penicillin/streptomycin. The lymphoblast lines used in this study as controls were originally obtained for carrier screening. No defect was found, and the samples were anonymized.

Unless otherwise stated, . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.